Search

Search Constraints

You searched for: Author/Creator Hong, David

Search Results

2. Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors. Issue 1 (December 2017)

4. Synthesis, insecticidal activities and resistance in Aedes albopictus and cytotoxicity of novel dihaloacetylated heterocyclic pyrethroids. Issue 2 (27th August 2019)

6. 8 Immune correlates associated with clinical outcomes in patients with advanced malignancies treated with avelumab and OX40 agonist. (10th December 2020)

7. 379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor. (9th November 2020)

8. 8 Immune correlates associated with clinical outcomes in patients with advanced malignancies treated with avelumab and OX40 agonist. (9th November 2020)